Iron is tightly connected to oxygen homeostasis and erythropoiesis. Our aim was to better understand how hypoxia regulates iron acquisition for erythropoiesis in humans, a topic relevant to common hypoxia-related disorders. Forty-seven healthy volunteers participated in the HIGHCARE project. Blood samples were collected at sea level and after acute and chronic exposure to high altitude (3400 to 5400 meters above sea level). We investigated the modifications in hematocrit, serum iron indices, erythropoietin, markers of erythropoietic activity, interleukin-6 and serum hepcidin. Hepcidin decreased within 40 hours after acute hypoxia exposure (p<0.05) at 3400 meters, reaching the lowest level at 5400 meters (80% reduction). Erythropoietin significantly increased (p<0.001) within 16 hours after hypoxia exposure followed by a marked erythropoietic response supported by the increased iron supply. Growth differentiation factor-15 progressively increased during the study period. Serum ferritin showed a very rapid decrease suggesting the existence of hypoxia-dependent mechanism(s) regulating storage iron mobilization. The strong correlation between serum ferritin and hepcidin at each point during the study indicates that iron itself or the kinetics of iron utilization in response to hypoxia may signal hepcidin downregulation.
Introduction
Iron is an essential element required as a cofactor for proteins managing oxygen transport such as hemoglobin, myoglobin and cytochromes. Hypoxia, that occurs in a broad range of pathologic or environmental conditions, is primarily sensed in vertebrates by the hypoxia inducible family of transcription factors (HIFs) which activate or repress genes involved in adaptations to low oxygen pressure 1 . In the erythropoietic compartment, which contains approximately 70% of the body iron, hypoxia stimulates erythropoiesis and promotes hemoglobin synthesis which largely depends on iron availability [2] [3] [4] [5] [6] . Accordingly, both hypoxia and anemia induce the synthesis of erythropoietin (EPO) and are the two main signals which increase iron absorption independently of iron stores [6] [7] [8] [9] .
Thus, iron metabolism is tightly connected to oxygen homeostasis and erythropoiesis.
The liver peptide hepcidin, codified by HAMP, is the key regulator of iron homeostasis. It acts by inhibiting intestinal iron absorption and release by macrophages and its production is regulated by different stimuli including inflammatory cytokines 10 , iron 11 , erythropoietic activity [12] [13] [14] , anemia and hypoxia [15] [16] [17] mainly at the transcriptional level as described in recent reviews 18, 19 . Anemia could mediate hepcidin suppression through multiple mechanisms including increased EPO or erythropoietic activity, increased iron demand or liver hypoxia 3 . The nature of the erythropoietic regulator of hepcidin is still uncharacterised, but may include one or more proteins released during active erythropoiesis. One of these regulators, GDF15, a divergent member of the transforming growth factor-beta super-family, has been identified also as an oxygen-regulated transcript responding to hypoxia 20 , suggesting that some homeostatic systems for iron and oxygen are responsive to both stimuli.
Previous studies reported a decrease of hepcidin expression in response to hypoxia 17 , however the physiological relevance and the mechanisms of hepcidin regulation by hypoxia are still uncertain and conflicting 12, 15, 16, 21, 22 . There is limited information on the hypoxia-induced modifications of mediators of iron homeostasis in vivo in humans. High altitude induces several physiological changes due to hypobaric hypoxia and healthy subjects exposed to high altitude represent a
For personal use only. on October 15, 2017 . by guest www.bloodjournal.org From convenient model to study these changes after acute or chronic exposure to hypoxia 4 . The present study exploits a unique human resource: the availability of biological material from normal volunteers participating in the HIGHCARE (HIGH altitude Cardiovascular Research) 2008 project on Mount Everest south slopes in Himalaya. We planned to investigate the modifications induced by acute and chronic exposure to hypobaric hypoxia on serum iron indices, EPO, markers of increased erythropoietic activity and inflammation, and hepcidin itself. Our aim was to better understand how hypoxia regulates iron acquisition for the erythropoietic response, a topic relevant to several common hypoxia-related human disorders, that include both acute conditions and chronic disorders of aging, as heart failure, sleep-related breathing disorders, chronic bronchitis and anemia.
To the best of our knowledge, this is the first study that examined in humans the temporal association between high altitude-induced changes in circulating hepcidin and serum iron indices, markers of increased erythropoietic demand and known soluble regulators of iron homeostasis in order to obtain information on how hypoxia modulates in vivo the biological response aimed to supply iron essential for erythropoiesis.
Materials and Methods
Participants. We enrolled 47 healthy volunteers (32 males and 15 females) in good general health, living permanently at less than 500 m above sea level (a.s.l.). Exclusion criteria were: known cardiovascular disease, any chronic cardiovascular therapy, repeated prolonged exposures to altitudes >3000 m a.s.l. in the 8 months preceding the expedition, history of severe mountain sickness, history of angioedema and pregnancy. Professional athletes were not included in the study. Subjects underwent a general health check-up including exercise test and echocardiography prior to the expedition. All subjects gave their written informed consent to the study procedures.
The study protocol was approved by the Ethics Committee of Istituto Auxologico Italiano and the study was conducted in agreement with the Helsinki Declaration.
For personal use only. on October 15, 2017 . by guest www.bloodjournal.org From Six volunteers (five women and one man) were excluded from the study because they were iron deficient caused by menstrual blood losses (4 women) and blood donations (one man and one woman). They showed undetectable hepcidin levels at baseline and throughout the entire study.
Study design and procedures. Figure 1 summarizes the different steps of the study. The participants travelled by air from sea level (Milan, 140 m) to Kathmandu (Nepal, 1355 m) where they stayed for three days. Then they were brought by air transportation in a few hour time to Namche Bazaar (3400 m), where they stayed for another three days. From Namche Bazaar they trekked over 5 days to Mt. Everest south Base Camp (BC, 5400 m) where they remained for 11 days. They returned to sea level (Milan) over the next 6 days. During the study all volunteers were on the same standard diet. Samples were collected at five time points: sea level baseline (SL1), during acute (day [1] [2] exposure to high altitude (3400 m) at Namche Bazaar (Namche), during acute (day 10-12) and prolonged (day [19] [20] exposure to very high (5400 m) altitude at Mt. Everest Base Camp (BC1 and BC2, respectively) and again 3-4 months after returning to sea level (SL-return). In order to evaluate the different timing of EPO, hepcidin and hepcidin regulators response to acute hypoxia stimulation, volunteers were divided in two subgroups, matched for age and sex, which were tested at 16 (first morning after arrival at Namche) and 40 hours (next morning) after acute exposure at 3400 meter above the sea level. These two groups are classified as Namche group A (n= 20) and B (n= 21), respectively.
Experiments in Namche Bazaar were performed in comfortable hotel rooms while at BC they were performed in heated tents. Both in Namche Bazaar and in BC, laboratory temperature and barometric pressure were recorded by means of a microclimatic station. In the morning of the first and second day after arrival at Namche Bazaar as well as on days 10-12 and 19-20 at BC we measured several parameters including heart rate, systemic blood pressure, respiratory rate, body temperature and oxygen saturation. Blood samples were always obtained in the morning (between 7 and 9.30 a.m.) at fast, after the subject has been sitting for at least 15 minutes. Samples were immediately centrifuged and sera stored at -80° C at sea level, while during the expedition they confidence intervals, and quartiles. We remark that at Namche, two volunteers, both belonging to Namche Group A, showed a marked increase of serum hepcidin (from 5.3 to 171 ng/ml and 72 to 184 ng/ml, respectively) which paralleled marked IL-6 increments (from 49.1 to 267.54 pg/mL and from 16.4 to 107.5 pg/mL, respectively). These alterations were probably due to an upper airway infection they developed in the first days after the arrival in Nepal. Accordingly, both hepcidin and IL-6 levels rapidly decreased at subsequent tests. This justified the exclusion of these values from all the longitudinal analyses, as explicitly indicated in the results and tables.
The evaluation of the changes in the log-measurements over altitude was done by fitting mean response profiles models 24 , testing the effect of altitude, sex and the interaction altitude by sex.
Results were reported for the final model including only significant effects (cut-point for significance = 0.01). An unstructured form of the variance-covariance matrix was used as it
For personal use only. on October 15, 2017. by guest www.bloodjournal.org From minimized Akaike information criterion (AIC), compared to a set of competing forms (i.e. compound symmetry, heterogeneous autoregressive, exponential). When a significant overall effect of altitude was detected, contrasts between baseline (SL1) and the subsequent measurements (Namche, BC1 and BC2), and between the mean values at Namche and at BC1 were evaluated.
Moreover, in case of a significant interaction term, the comparisons were performed separately for males and females. The same modelling approach was used for the analysis of changes in parameters after acute exposure to altitude at Namche as measured after 16 or 40 hours of exposure to hypoxia (group A and B).
In order to evaluate the influence of regulators of hepcidin, a multivariate linear regression model was considered. Regressors were screened in a univariate analysis for each parameter on loghepcidin at each altitude. The multivariate model included those parameters which were significant in at least one univariate analysis (p-value<0.01), and were adjusted for age and gender. Table 1 shows volunteers' characteristics at baseline (SL1) divided according to gender. As expected hematocrit, serum ferritin and hepcidin were lower in women than in men. Means and medians of the parameters studied at SL1, Namche, BC1 and BC2, and SL-return are reported in Table 2 . All the changes that occurred at high altitude had disappeared by the time of measurement at sea level three months after return. Figure 2 shows the time course of each parameter at baseline and during the period of hypoxic exposure with geometric means and 95% confidence intervals. We observed overall a significant increase of hematocrit from baseline (42.1%; 95% CI 40.9-43.4) to BC2 (54.1%; 95% CI 52.7-55.6). This increase was evident both in men (from 43.5 to 55.5 %) and women (from 38.2 to 50.4 %) but women always maintained significantly lower values than men.
Results
We observed a significant increase of hematocrit at Namche, but this was probably due to the rapid decrease of plasma volume associated with acute exposure to hypoxia 25 not adequately compensated by increased water assumption. This is supported by the fact that the increase was As shown in Figure 2 and in Table 2 , hepcidin levels significantly decreased after acute exposure to hypoxia (Namche) reaching the nadir at BC1 and BC2, when its levels were reduced by more than 80%. While males and females started from different baseline values, their decreasing profile did not differ significantly according to the longitudinal analysis (Suppl. Table 1 ). EPO rapidly increased at Namche maintaining a plateau at BC1 and beginning to decrease at BC2. Transferrin saturation augmented at Namche exclusively due to transient serum iron increase, because serum transferrin showed a rapid and gradual increase likely related to iron depletion. It significantly decreased at BC1, due to the increased iron utilization by the bone marrow, and remained fairly similar at BC2. The decrease of transferrin saturation was more evident for females than males (with a significant interaction term in the longitudinal model, see Suppl. Table 1 ). Serum ferritin showed a rapid and progressive decrease that was already evident at Namche, indicating massive mobilization of iron from stores. This progressive decrease was similar in males and females so that a significant difference by gender was maintained in the longitudinal profile. The three remaining parameters did not behave differently by gender but were affected by altitude. Specifically, sTFR showed a marked increase from Namche to BC1 according to erythropoietic expansion, whereas GDF15 showed a progressive, but slight increase from SL1 to Namche and BC1, both maintaining a plateau at BC2. IL-6 levels increased at Namche and remained elevated at BC1 and BC2. As shown by the results of the model on longitudinal profiles (Suppl. Table 1), changes from acute (Namche) versus chronic (BC1) hypoxia were significant for all parameters, except for EPO, which showed the major increase at Namche.
To better evaluate the time course of each parameter in response to acute hypoxia we examined the results at 16 (Namche group A) and 40 (Namche group B) hours after acute hypoxia exposure (Table 3) . Groups A and B had comparable baseline values for all parameters (p-values>0.05).
For
EPO, GDF15, transferrin and ferritin significantly changed both in Namche group A and group B.
After 40 hours, serum iron significantly augmented causing transferrin saturation increase. Hepcidin did decrease after 16 hours but not significantly so (p-value=0.0869), whereas it significantly decreased after 40 hours of exposure. Accordingly, only nine out of the 18 volunteers (50%) of group A showed a reduction of hepcidin levels as compared to 17 out of 21 (81%) in group B.
Changes in IL-6 were more marked after a longer exposure, while sTFR did not show significant modifications in both groups
Trying to evaluate the relations between hepcidin and its possible regulators (erythropoietic activity, iron stores, cytokine activation), we performed univariate and multivariate analyses at different times of exposure to hypoxia. Results of univariate analyses were used to screen for relevant factors to be included in the multivariate analysis. In the univariate analysis (data not shown), serum ferritin correlated with serum hepcidin at each point, while EPO inversely correlated with hepcidin only at BC1. Results of the multivariate model at different altitudes are reported in Suppl. Table 2 .
Serum ferritin seems to be the only independent predictor for hepcidin: a 10% decrease in serum ferritin is estimated to be related to a decrease in hepcidin of 6.5%, 7.3%, 7.6% and 8.2% at SL1, Namche, BC1 and BC2, respectively.
Discussion
During the 20 days period of high altitude exposure we observed a marked increase of hematocrit which required about 700 mg iron in men and 400 mg in women (based on approximate calculation of hemoglobin increase, hemoglobin iron content and subjects' weight and blood volume 26 ). To compensate for this massive demand of iron by erythropoietic precursors, iron release from stores and intestinal absorption had to increase dramatically. Our results strongly suggest that hepcidin downregulation was central to these modifications.
Hepcidin suppression began some hours after acute hypoxia exposure reaching its nadir in the following week of exposure to high altitude. The timing of hepcidin suppression we observed is 27, 28 . The delay and progression in hepcidin down-regulation contrasts with the hypothesis that hypoxia might directly be involved in hepcidin suppression and suggests that other factors are involved. Hypoxia generates a detectable increase in serum EPO within 90 minutes 9 , which peaks within 2 days and thereafter declines over a period of 1-2 weeks in volunteers exposed to high altitude 6 . Accordingly, we observed a rapid and marked increase of EPO which was maintained at BC1 and began to decline at BC2. It has been suggested that hypoxia could act on hepcidin down-regulation via EPO signaling 27, 29 , but animal studies indicated that the decrease of hepcidin expression by experimentally induced anemia was dependent on erythropoiesis and not directly mediated by EPO, anemia, or tissue hypoxia 12, 14 . The present study could not clarify this issue, but considering that hepcidin is a fast-responding hormone and that the timing of hepcidin suppression was gradual, we suggest that it could be mediated by circulating factor(s)
released by cells in response to hypoxia-induced erythropoietic activation. Recent observations have indicated that GDF15 and twisted gastrulation 1 (TWSG1) could be erythropoietic regulators of hepcidin 13, 30 possibly opposing the effect of BMPs
31
. GDF15 is expressed during erythroblast maturation mainly in more mature, hemoglobinized erythroblasts 32 whereas TWSG1 is produced during the earlier stages of erythropoiesis 30 . GDF15 is highly expressed in thalassemia 13 , congenital diserythropoietic and sideroblastic anemias 32, 33 , and less in other forms of ineffective erythropoiesis 13, [32] [33] [34] . In addition, GDF15 was up-regulated in response to iron depletion in in vitro and human studies 20 , but to a smaller extent (two-fold or less). A similar magnitude of increase was observed in our volunteers who showed a progressive GDF15 increase which peaks at BC2.
This was likely the result of the combined action of erythropoiesis activation, iron depletion, but also of tissue hypoxia, inflammation or enhanced oxidative stress induced by high altitude exposure 20, 35 . However, GDF15 levels were below the threshold that down-regulated HAMP mRNA in primary hepatocytes in vitro 13 and did not show any correlation with hepcidin suggesting that GDF15 could cooperate to hepcidin suppression, but cannot be a main regulator in this setting. Among all the parameters analysed, serum ferritin was the one showing the best correlation with hepcidin at each point during the study suggesting that iron itself, or the kinetics of iron utilization in response to hypoxia, may signal the suppression of hepcidin. At variance with that observed in patients with ineffective erythropoiesis in whom the hepcidin store regulator is overwhelmed by the erythroid signal 3 , our results indicate that in healthy individuals exposed to acute and chronic hypoxia, hepcidin production is modulated by the iron store regulator even in the presence of increased erythropoietic demand.
Unexpectedly, we observed a significant decrease of serum ferritin concentration in the very early stages of hypoxia exposure (16 hours) when there was no evident increase of erythropoiesis and hepcidin was not suppressed, yet. This finding contrasts with those induced by prolonged rhEpo treatment in healthy subjects showing a later decrease of serum ferritin secondary to erythropoiesis expansion and increased iron demand 27, 28 . In animal models, stabilization of HIF in hepatocytes increases ferroportin expression possibly due to a HIF-dependent ferroportin mRNA up-regulation and/or to a post-translational stabilization of ferroportin 16, 36 . Thus, we can hypothesise that acute hypoxia might induce a rapid mobilization of iron from storage cells to plasma in order to ensure enough iron to the mounting red blood cells hemoglobinization. The increase of serum iron and transferrin saturation observed at 40 hours might indicate that iron mobilisation was even higher than bone marrow request in this phase. Further studies are needed to confirm and extend all these findings.
At BC1 and BC2 the increased rate of erythropoiesis was paralleled by the marked decrease of tissue iron stores and increased iron utilization by the erythropoietic bone marrow, as shown by the marked reduction of serum ferritin and transferrin saturation which likely cooperated to further suppress hepcidin synthesis 18 . A recent study suggested that besides liver and spleen, skeletal muscle tissue can be another source of iron during high altitude-induced erythropoiesis 37 . This finding differs from that observed in healthy volunteers treated with rhEpo at sea level in whom skeletal muscle accumulated iron, despite systemic iron deficiency secondary to rhEpo-induced 27 . It was hypothesized a role of hypoxia in triggering muscle iron mobilization by increasing ferroportin mRNA and decreasing transferrin receptor mRNA expression 27 . These findings further emphasize the difference between accelerated erythropoiesis induced by rhEpo administration and hypoxia.
In agreement with previous studies 35 we found an early and stable increase of IL-6 concentrations, which remained below the range expected in inflammatory diseases. The mild systemic inflammation induced by exposure to high altitude, however, did not substantially counteract hypoxia-induced hepcidin suppression. In fact, only the two volunteers who developed an upper respiratory infection at the very beginning of hypoxia exposure showed a marked increase of both IL-6 and hepcidin. The progressive decrease of hepcidin, despite the persistent slight increase of IL-6, and the absence of correlation between hepcidin and IL6 suggest that iron and erythroid signals prevailed on inflammation for hepcidin regulation in this setting as also shown in mouse models combining inflammation and erythropoiesis stimulation 38 .
In conclusion, our results provide new insights into the interaction between hypoxia, erythropoiesis and iron metabolism in humans. In Figure 3 we summarised the physiological modifications induced by acute and chronic hypoxia exposure on iron homeostasis aimed at supplying enough iron to the bone marrow, mainly based on the present findings. Hypoxia induced a marked suppression of hepcidin which appeared to result from the combined action of hypoxia-induced increased erythropoiesis and iron depletion. Serum ferritin was a major determinant of serum hepcidin concentration whereas the role of EPO and GDF15 seemed less important. This entails new efforts aimed to discover other erythroid regulator(s) of hepcidin expression. Last, the very early decrease of serum ferritin suggests the existence of hypoxia-dependent and hepcidinindependent mechanisms regulating storage iron mobilization. These results could have implications for hypoxia-related acute and chronic disorders, contributing to explain the role of hepcidin in the pathophysiology of hypoxia adaptation. They represent a first innovative step and 
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